Even though patients are often taking the exact same drug at the same or slightly adjusted doses, what changes is how they want to buy it and the level of care associated with it, and I think this explains why many customers switch and migrate to simpler, more transactional services where they can get their medication without the ankle-monitor and simply get on with their lives
Final thoughts and next steps The market is evolving rapidly
Decoding the implications of glucagon-like peptide-1 receptor agonists on accelerated facial and skin aging
This transition in the market arises due to the changing approach towards obesity being considered as a chronic disease, with comorbidities such as type 2 diabetes and other diseases
Werner JA, Davies R, Wahlstrom J, Dahal UP, Jiang M, Stauber J, et al